Triptorelin pamoate is used to treat advanced prostate cancer by suppressing testosterone production. It’s also prescribed for endometriosis and uterine fibroids to lower estrogen levels. In children, it treats central precocious puberty by delaying early hormonal development. As a long-acting GnRH agonist, it offers sustained hormone suppression through depot injections. It is grouped under the following drug class(es): Antineoplastic agents, LHRH analogues and Peptides. Its therapeutic use is listed as antineoplastics. The directory classifies it as a commercial API with a peptide source/manufacturing origin. Other names for this substance include Decapeptyl, Triptorelin Embonate and Trelstar. Its PubChem CID is 25074469.
Triptorelin pamoate
| CAS No | 124508-66-3 |
|---|---|
| Molecular Formula | C87H98N18O19 |
| Molecular Weight | 1699.8 g/mol |
| Synonyms | (2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[(2-amino-2-oxoethyl)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide;4-[(3-carboxy-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Triptorelin pamoate is used to treat advanced prostate cancer by suppressing testosterone production. It’s also prescribed for endometriosis and uterine fibroids to lower estrogen levels.
The listed CAS number is 124508-66-3.
The listed molecular formula is C87H98N18O19.
The listed molecular weight is 1699.8 g/mol.
The source lists Decapeptyl, Triptorelin Embonate and Trelstar.
Its therapeutic use is listed as antineoplastics.